Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness of antihypertensive treatment. General considerations.

L B Russell1

  • 1Institute for Health, Rutgers University, New Brunswick, NJ 08903.

Hypertension (Dallas, Tex. : 1979)
|May 1, 1989
PubMed
Summary

Cost-effectiveness analysis evaluates medical interventions. Newer hypertension drugs may offer better value than traditional treatments, aiding healthcare decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease.

American heart journal·2024
Same author

Radiation-induced genetic damage in mice.

Progress in nuclear energy. Series 6 Biological sciences·2014
Same author

An allelic series of mutations in the kit ligand gene of mice. I. Identification of point mutations in seven ethylnitrosourea-induced Kitl(Steel) alleles.

Genetics·2002
Same author

An allelic series of mutations in the Kit ligand gene of mice. II. Effects of ethylnitrosourea-induced Kitl point mutations on survival and peripheral blood cells of Kitl(Steel) mice.

Genetics·2002
Same author

The methodologic partnership of effectiveness reviews and cost-effectiveness analysis.

American journal of preventive medicine·2001
Same author

Sequence interpretation. Functional annotation of mouse genome sequences.

Science (New York, N.Y.)·2001

Area of Science:

  • Health economics
  • Pharmacoeconomics
  • Clinical decision-making

Background:

  • Cost-effectiveness analysis (CEA) is crucial for comparing medical interventions.
  • Hypertension treatment involves balancing costs and health outcomes.
  • Novel drug classes present alternatives to traditional hypertension therapies.

Purpose of the Study:

  • To outline fundamental principles of cost-effectiveness analysis.
  • To discuss characteristics of cost-effective hypertension therapies.
  • To compare newer hypertension drugs with traditional treatments.

Main Methods:

  • Review of cost-effectiveness analysis principles.
  • Discussion of economic evaluation criteria for medical interventions.
  • Focus on specific drug classes: ACE inhibitors, alpha-blockers, calcium antagonists.

Main Results:

  • CEA provides a framework for comparing treatment options.
  • Specific characteristics are required for alternative therapies to be more cost-effective.
  • Newer hypertension drugs (ACE inhibitors, alpha-blockers, calcium antagonists) are key areas for CEA.

Conclusions:

  • Cost-effectiveness analysis is essential for informed healthcare policy.
  • Identifying cost-effective hypertension treatments is vital for resource allocation.
  • Further economic evaluations are needed for emerging hypertension pharmacotherapies.

Related Experiment Videos